Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Co

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Conducted by Aethlon's Exosome Sciences Subsidiary Source: Gail Dutton of The Life Sciences Report (12/22/15) https://www.thelifesciencesreport.com/pub/na/aethlon-medical...
Gail Dutton | December 23, 2015 |

Cracking the Code to Society’s Most Feared Disease

Even more so than cancer, it’s the one disease that we all fear the most. The thought of falling prey to Alzheimer’s disease and to the inevitable desecration of our mind is something that makes even the bravest among us shudder. ...
Marc Davis | February 7, 2020 |

Three Charts Every Trader and Investor Must See

Understanding the stock market and its potential through the use of technical analysis and historical price events has been proven repeatedly to outperform all forms of fundamental trading styles. The following is a story that walks you through my experience, the shift in my...
Chris Vermeulen | March 30, 2020 |

Alzheimer’s Solution Shows Promise after Big Pharma’s Cure Fails

Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug ontheir research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account f...
Stockhouse Editorial | March 28, 2019 |

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...
Streetwise Reports | April 9, 2020 |

dynaCERT Embarking on Tokenization of Carbon Credit Market

A first-generation end-to-end carbon credit marketplace tokenization system appears now under development leveraging dynaCERT’s unique patented and proven technology. Newly appointed FinTech pioneer to dynaCERT’s Advisory Board stated, “ Digiti...
James O'Rourke | March 4, 2019 |

Multi-billion dollar valuation set for dynaCERT Inc. (V.DYA), pieces falling into place

dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) this week announced it has received its European ABE (German for “permit of operation”) certification for the Company’s HydraGEN™ (HG) Carbon Emission Reduction Technology fo...
James O'Rourke | August 27, 2019 |

Repeating Patterns In Human Behavior

GREED AND FEAR The January 1987 edition of Military Review, a professional journal of the U.S. Army, noted: “Since the mind of the individual soldier has not changed and fear is the crucial factor in the outcome of all battles, tactics must be directed not just against...
Chris Ciovacco | December 23, 2019 |

dynaCERT Inc. CEO Interview on Bloomberg BNN

dynaCERT is expecting to turn ‘cash flow positive/profitable’ later this 2019 and appears poised to generate increasingly healthy returns thereafter. Global demand potential for dynaCERT's HG technology is in the multi-millions of units. Market Equities R...
James O'Rourke | April 30, 2019 |

Stocks to Watch: DynaCERT Inc. poised for exponential move

The level of interest for dynaCERT’s award winning HydraGEN (HG) technology is building globally as a solution to the problem of harmful exhaust emissions plaguing cities across the world. It appears only a matter of time before the demand growth cu...
Fredrick William | July 9, 2019 |
1 2 3 4 5 6 7 8 9 10 ...